Better Life Science continues strengthening its direct-to-consumer testing platform by integrating ongoing health education alongside its at-home diagnostic services.
In addition to operating a CLIA-certified laboratory and offering at-home testing across multiple categories, Better Life Science provides consumer-facing educational resources, addressing commonly misunderstood health scenarios, including sexual health screening considerations, tick bite response and allergy awareness, helping individuals better understand when testing may be appropriate and how to act on results.
“Testing alone doesn’t solve the problem if people don’t have context,” said a Better Life Science company representative. “Clear, practical education supports better decision-making and builds long-term trust in the testing process.”
ABOUT BETTER LIFE SCIENCE:
Better Life Science is a CLIA-certified laboratory providing direct-to-consumer at-home health testing designed to improve access to reliable diagnostics while maintaining clinical accuracy, privacy and regulatory compliance. Founded by a team of scientists, medical professionals and entrepreneurs, the company developed its model to reduce delays and barriers commonly associated with traditional healthcare systems.
Through its direct-to-consumer platform, Better Life Science offers at-home testing across multiple categories, including sexually transmitted infection testing, food intolerance testing and food and inhalant allergy testing, supported by a portfolio of consumer-facing brands such as STD Hero, Rx Hero, Allergy Hero, Tick Bite Hero, Pet Test Hero and Fight Night Hero. The company also maintains an education-first approach, providing resources that help individuals better understand health risks, testing timelines and preventive considerations.
Better Life Science is led by CEO Alan Brock and COO Daniel Fontenot, with laboratory oversight from Dr. David Eagerton and Dr. William Budd, and operates with core values centered on accuracy, accessibility, integrity, empathy, innovation, partnership and community, as it continues advancing a modern diagnostic model focused on clarity, trust and practical health access.
MEDIA CONTACT: BSG PR / 818.340.4422 / brian@bsgpr.com / @bsgpr
